Perspective Therapeutics (CATX) Enterprise Value (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -237.06%
Dec 31, 2025 16.88%
Sep 30, 2025 50.85%
Jun 30, 2025 6.51%
Mar 31, 2025 -67.02%
Dec 31, 2024 26.61%
Sep 30, 2024 -5.58%
Jun 30, 2024 -62.12%
Mar 31, 2024 -1,855.49%
Dec 31, 2023 48.63%
Sep 30, 2023 36.50%
Jun 30, 2023 22.31%
Mar 31, 2023 16.69%
Dec 31, 2022 19.14%
Sep 30, 2022 3.18%
Jun 30, 2022 5.12%
Mar 31, 2022 2.40%
Dec 31, 2021 2.17%
Sep 30, 2021 3.35%
Jun 30, 2021 1.56%
Mar 31, 2021 -576.48%
Dec 31, 2020 -394.07%
Sep 30, 2020 18.90%
Jun 30, 2020 0.54%
Mar 31, 2020 24.37%
Dec 31, 2019 30.49%
Sep 30, 2019 14.10%
Jun 30, 2019 16.68%
Mar 31, 2019 18.76%
Dec 31, 2018 14.41%
Sep 30, 2018 -168.41%
Jun 30, 2018 24.14%
Mar 31, 2018 20.45%
Dec 31, 2017 21.78%
Sep 30, 2017 19.12%
Jun 30, 2017 13.80%
Mar 31, 2017 12.89%
Dec 31, 2016 12.85%
Sep 30, 2016 -10.67%
Jun 30, 2016 -6.73%
Mar 31, 2016 7.88%
Dec 31, 2015 -693.30%
Sep 30, 2015 89.12%
Jun 30, 2015 -1,253.99%
Mar 31, 2015 19.40%
Jun 30, 2014 25.40%
Mar 31, 2014 -436.92%
Dec 31, 2013 16.46%
Sep 30, 2013 -82.22%
Jun 30, 2013 21.29%
Mar 31, 2013 17.04%
Dec 31, 2012 11.69%
Sep 30, 2012 -88.15%
Jun 30, 2012 -5.88%
Mar 31, 2012 26.53%
Dec 31, 2011 -115.49%
Sep 30, 2011 24.51%
Jun 30, 2011 39.23%
Mar 31, 2011 -25.47%
Dec 31, 2010 -170.39%